Brain Phosphatidylcholine Pools as Possible Sources of Free Choline for Acetylcholine Synthesis

  • M. Lakher
  • R. J. Wurtman
  • J. Blusztajn
  • P. Holbrook
  • J-C. Maire
  • C. Mauron
  • M. Tacconi
Chapter
Part of the Experimental Biology and Medicine book series (EBAM, volume 12)

Abstract

Choline in cholinergic neurons has two fates: it is a constituent of phosphatidylcholine (PC) and other phospholipids (sphingomyelin, choline plasmalogens, lysophosphatidylcholine) and is used as a precursor for synthesis of a neurotransmitter, acetylcholine (ACh). The pool of PC in the brain (about 16 µmol/g tissue) is several orders of magnitude larger than the pools of free choline and ACh. A number of experimental observations support the hypothesis that at least a portion of this lipid-bound choline can provide free choline for ACh formation. Firstly, more choline molecules leave the brain than enter it (i.e., there is a negative arteriovenous difference) (Dross & Kewitz, 1972; Aquilonius et al., 1975; Choi et al., 1975; Spanner et al., 1976), even though lipid-bound circulating PC apparently does not enter the brain (Pardridge et al., 1979), indicating that brain cells both produce choline-containing compounds (like PC) de novo, and liberate free choline from these larger molecules. Secondly, when labelled choline was infused intravenously into rats, specific radioactivities of free choline in the brain were found to be lower than those in the blood or liver, suggesting that unlabelled choline, produced within the brain, was diluting the material taken up from the blood (Choi et al., 1975; Kewitz & Pleul, 1976; Spanner et al., 1976). Thirdly, consumption of a choline-deficient diet had no effect on the striatal levels of choline and ACh in rats, even though blood choline concentrations were markedly decreased (Millington & Wurtman, 1982).

Keywords

Unpublished Experiment Methylation Pathway Free Choline Acetylcholine Synthesis Choline Plasmalogens 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aquilonius, S.M., Cedar, G., Lying-Tunell, U., Malmund, H.O. and Schubert, J. (1975) Brain Res. 99, 430–433PubMedCrossRefGoogle Scholar
  2. Ansell, G.B. and Spanner, S. (1971) Biochem.J. 122, 741–750PubMedGoogle Scholar
  3. Ansell, G.B. and Spanner, S. (1981) in Advances in Behavioral Biology 25, Cholinergic Mechanisms (Pepeu, G. and Ladinsky, H., Eds.) pp.393–403, Plenum Press, New YorkGoogle Scholar
  4. Blusztajn, J.K. and Wurtman, R.J. (1980) Nature 290, 417– 418CrossRefGoogle Scholar
  5. Blusztajn, J.K., Chapman Lingham, C., Richardson, U.I. and Wurtman, R.J. (1985) Int.Soc.Neurochem., Satellite Meeting, Abstract P18, 66Google Scholar
  6. Chida, N. and Arakawa, T. (1971) Tohoku J.exp.Med. 104, 359–371PubMedCrossRefGoogle Scholar
  7. Choi, R.L., Freeman, J.J. and Jenden, D.J. (1975) J.Neurochem. 24, 735–741PubMedGoogle Scholar
  8. Dross, K. and Kewitz, H. (1972) Naunyn-Scmiedberg’s Arch. Pharmacol. 274, 91–106CrossRefGoogle Scholar
  9. Folch, J., Lees, M. and Sloanne-Stanley, G.H. (1957) J.Biol.Chem. 226, 497–509PubMedGoogle Scholar
  10. Gharib, A., Sarda, N., Chabannes, B., Cronenberger, L. and Pacheco, H. (1982) J.Neurochem. 38, 810–815PubMedCrossRefGoogle Scholar
  11. Glenn, J.L. and Austin, W. (1971) Biochim.Biophys.Acta 231, 153–160PubMedGoogle Scholar
  12. Kanfer, J.N. (1972) J.Lipid Res, 13, 468–477PubMedGoogle Scholar
  13. Kewitz, H. and Pleul, O. (1976) Proc.Natl.Acad.Sei.USA 73, 2181–2185CrossRefGoogle Scholar
  14. Maire, J-C., Tacconi, M. and Wurtman, R.J. (1983) Soc. Neurosci. 9, Abstract 283.8Google Scholar
  15. Mann, S.P. (1975) Experientia 31, 1256–1257PubMedCrossRefGoogle Scholar
  16. Millington, W.R. and Wurtman, R.J. (1982) J.Neurochem. 38, 1748–1752PubMedCrossRefGoogle Scholar
  17. Morganstern, R.D. and Abdel-Latif, A.A. (1974) J.Neurobiol. 5, 393–411PubMedCrossRefGoogle Scholar
  18. Neff, N.H., Spano, P.F., Gropetti, A., Wang, C.T. and Costa, E. (1974) J.Pharm.Exp.Ther. 176, 701–710Google Scholar
  19. Pardridge, W.M., Cornford, E.M., Braun, L.D. and Oldendorf, W.H. (1979) in Nutrition and Brain 5, Choline and Lecithin in Brain Disorders (Barbeau, A., Growdon, J.H. and Wurtman, R.J., Eds.) pp.25–34, Raven Press, New YorkGoogle Scholar
  20. Parducz, A., Kiss, Z. and Joo, F. (1976) Experientia 32, 1520–1521PubMedCrossRefGoogle Scholar
  21. Porcellati, G., Goracci, G. and Arienti, G. (1983) in Handbook of Neurochemistry 5, Metabolic Turnover in the Nervous System (Lajtha, A., Ed.) pp.277–294, Plenum Press, New York and LondonGoogle Scholar
  22. Schneider, W.J. and Vance, D.E. (1978) Eur.J.Biochem. 85, 181–187PubMedCrossRefGoogle Scholar
  23. Spanner, S., Hall, R.C. and Ansell, G.B. (1976) Biochem.J. 154, 133–140PubMedGoogle Scholar
  24. Sun, G.Y., Tang, W., Majewska, M.D., Hallett, D.W., Foudin, L. and Huang, S. (1983) in Neural Membranes (Sun, G.Y., Bazan, N., Wu, J-Y., Porcellati, G. and Sun, A.Y., Eds.) pp.67–95, Humana Press, Clifton, New JerseyGoogle Scholar
  25. Zawad, J.S. and Brown, F.C. (1985) J.Neurochem. 44, 808– 811PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc. 1986

Authors and Affiliations

  • M. Lakher
    • 1
  • R. J. Wurtman
    • 1
  • J. Blusztajn
    • 1
  • P. Holbrook
    • 1
  • J-C. Maire
    • 1
  • C. Mauron
    • 1
  • M. Tacconi
    • 1
  1. 1.Massachusetts Institute of TechnologyCambridgeUSA

Personalised recommendations